News from NORD

NIH Workshop Focuses on Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Publish date: May 10, 2017

 

NIH recently hosted a workshop to bring researchers together to discuss severe drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and possible genetic factors that might predispose individuals to greater risk.

Recommended Reading

Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone
MDedge Dermatology
New diagnostic tool identifies severe ADAMTS13 deficiency
MDedge Dermatology
Infliximab safe for recently vaccinated Kawasaki patients
MDedge Dermatology
DTC genetic health risk tests: Beware
MDedge Dermatology
VIDEO: Surgery succeeds with select hidradenitis suppurativa patients
MDedge Dermatology
Patient Advocacy Groups Oppose AHCA
MDedge Dermatology
NORD Issues RFPs for 2017 Research Grants for Study of Rare Diseases
MDedge Dermatology
NORD Rare Action Network Issues Spring 2017 State Policy Legislative Tracker
MDedge Dermatology
Central centrifugal cicatricial alopecia can affect adolescents
MDedge Dermatology
In pyoderma gangrenosum, cyclosporine is cost effective for large lesions
MDedge Dermatology